Complications After Major Surgery for Duodenopancreatic Neuroendocrine Tumors in Patients with MEN1: Results from a Nationwide Cohort.

Dirk-Jan van BeekSjoerd NellWessel M C M VorselaarsBert A BonsingCasper H J van EijckHarry van GoorElisabeth J Nieveen van DijkumCornelis H C DejongGerlof D Valknull nullInne H M Borel RinkesMenno R Vriens

Published in: Annals of surgical oncology (2021)

Major duodenopancreatic surgery in MEN1 is associated with a very high risk of severe complications and cumulative burden of complications and should therefore be reserved for a select subgroup of patients with MEN1-related dpNETs.

Keyphrases

minimally invasive
neuroendocrine tumors
coronary artery bypass
middle aged
risk factors
surgical site infection
early onset
randomized controlled trial
coronary artery disease
percutaneous coronary intervention
drug induced